A European clinical trial found that sulthiame, a drug used in the treatment of epilepsy, reduced breathing interruptions.

Millions of people in the U.S. have sleep apnea, most of whom aren’t getting treated for it. But a simple daily pill of an ...

For decades, cumbersome CPAP machines have been the primary way to help people with sleep apnea. A range of new options has recently come into focus.

A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate to severe sleep apnea. Patients taking higher doses experienced up to 47% ...

(Tim Kitchen/Getty Images) Sleeping with a clunky breathing machine is a problem for many with sleep apnea, but a more comfortable alternative is on the horizon. In a recent clinical drug trial that ...

Incannex Healthcare Inc. (NASDAQ:IXHL) on Thursday detailed an updated clinical development plan for IHL-42X, its oral ...

Researchers say a medication originally used for epilepsy may significantly reduce breathing interruptions in people with sleep apnea, raising the possibility of a pill-based treatment.

A clinical trial shows sulthiame lowers breathing interruptions in sleep apnea and improves oxygen levels, raising hope for a medication alternative to CPAP therapy.

Researchers found that the medication sulthiame reduced breathing interruptions and improved oxygen levels overnight in people with moderate to severe sleep apnea. The findings were published recently ...

COLUMBUS, OH - February 24, 2026 - PRESSADVANTAGE - As awareness of obstructive sleep apnea continues to grow across ...

A nerve stimulator implant called Inspire is helping some sleep apnea patients breathe normally at night when a CPAP machine is not an effective treatment.

Incannex shares drop after announcing a $10 million stock offering to fund its IHL-42X sleep apnea study following positive ...